AEMD news & sentiment — AETHLON MEDICAL INC

MAR 23·Stock TitanLow

If You Invested $1,000 in Aethlon Medical (AEMD)

This article examines the historical performance of a hypothetical $1,000 investment in Aethlon Medical (AEMD) over 1, 5, and 10 years, showing significant losses compared to the S&P 500. It also provides a detailed overview of Aethlon Medical, a clinical-stage medical device company focused on its investigational Hemopurifier device for treating cancer and life-threatening infectious diseases, including specific regulatory designations and ongoing clinical research.

AUG 13·Motley Fool

Aethlon Medical Cuts Loss in Fiscal Q1

Aethlon Medical ( NASDAQ:AEMD ) , a medical technology developer focused on its lead Hemopurifier device for cancer and viral diseases, reported fiscal first-quarter results for the period ended June 30, 2025. The main news from the release was a narrowed loss per share for the three months ended ...

JUN 19·Benzinga

Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: Verified Market Research®

Lewes, Delaware, June 19, 2025 ( GLOBE NEWSWIRE ) -- The Global Exosome Research Market Size is projected to grow at a CAGR of 13.93% from 2026 to 2032, according to a new report published by Verified Market Research®.

$AEMD

If You Invested $1,000 in Aethlon Medical (AEMD)

Aethlon Medical Cuts Loss in Fiscal Q1

Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: Verified Market Research®

News on $AEMD